Home
Scholarly Works
167 The New Diabetes Drug Canagliflozin Enhances...
Journal article

167 The New Diabetes Drug Canagliflozin Enhances the Response of Prostate Cancer to Radiotherapy

Authors

Mekhaeil B; Zacharidis P; Tsakiridis E; Biziotis O-D; Broadfield L; Menjolian G; Mathurin T; Farrell T; Muti P; Liu S

Journal

Radiotherapy and Oncology, Vol. 139, , pp. s71–s72

Publisher

Elsevier

Publication Date

October 1, 2019

DOI

10.1016/s0167-8140(19)33223-2

ISSN

0167-8140

Contact the Experts team